Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Correction for Marsche et al., Arterioscler Thromb Vasc Biol 24 (12) 2302-2306.
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:264
doi: 10.1161/01.ATV.0000165504.53303.9c
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:264.)
© 2005 American Heart Association, Inc.

Correction


An extract of the first 100% of the full text is provided, because this article has no abstract.
 

In the December 2004 issue of Arteriosclerosis, Thrombosis, and Vascular Biology, in the article entitled "2-Chlorohexadecanal Derived From Hypochlorite-Modified High-Density Lipoprotein–Associated Plasmalogen Is a Natural Inhibitor of Endothelial Nitric Oxide Biosynthesis" by Marsche et al (Arterioscler Thromb Vasc Biol, 2004;24:2302–2306), the abbreviation of hypochlorous acid/hypochlorite in both the abstract and introduction of the article was erroneously listed as HOCl/Oce.

The abbreviation should have been set as HOCl/OCl.

The publisher regrets this error.